FDA updates labeling for ORLYNVAH
Labeling changes approved for ITERUM THERAP. Active ingredient: PROBENECID; SULOPENEM ETZADROXIL. Decision date: 12/23/2025
Labeling changes approved for ITERUM THERAP. Active ingredient: PROBENECID; SULOPENEM ETZADROXIL. Decision date: 12/23/2025
There are no comments here yet...